QPS, a full-service GLP/GCP-compliant contract research organization, has purchased a major stake in JSW Life Sciences. JSW provides preclinical and clinical Phase II - IV drug development services including project planning, project management, trial monitoring, database management, data analysis, medical writing and regulatory affairs. In addition, JSW provides genetically modified organisms for research in CNS diseases and combines behavioral analysis (cognition and motoric function), brain neurochemistry and biochemistry as well as quantitative histology and histopathology into preclinical research.
